Expression of PAX8-PPARγ1 rearrangements in both follicular thyroid carcinomas and adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3947-3952

  Marques, Ana Rita ^a   Espadinha, Carla ^a   Catarino, Ana L ^a   Moniz, Sónia ^a   Pereira, Teresa ^a   Sobrinho, Luís G ^a   Leite, Valeriano ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EXON; FOLLICULAR CARCINOMA; GENE ACTIVATION; GENE EXPRESSION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEEDLE BIOPSY; ONCOGENE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; THYROID ADENOMA; THYROID CARCINOMA; THYROID HYPERPLASIA;

ADENOMA; CARCINOMA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0036344885     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.8.3947     Document Type: Article

References (20)

1. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas
2. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
3. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma
4. Ligand for peroxisome proliferator receptor γ (troglitazone) has potent effect against human prostate cancer both in vitro and in vivo
5. Terminal differentiation of human breast cancer through PPARγ
6. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
7. A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW7845 inhibits rat mammary carcinogenesis
8. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer
9. Chromosome studies in thyroid neoplasia
10. Chromosomal changes in thyroid tumors. Relation with DNA content, karyotipic features, and clinical data
11. A t(2;3)(q12-13; p24-25) in follicular thyroid adenomas
12. ret/PTC-1, -2 and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential?
13. Distinct functional properties of three human paired-box-protein, PAX8 isoforms generated by alternative splicing in thyroid, kidney and Wilm's tumors
14. Involvement of RET oncogene in human tumors: Specificity of RET activation of thyroid tumours
15. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the ret/PTC1 oncogene in transgenic mice
16. Loss-of-function mutations in PPAR γ associated with human colon cancer
17. Isolation of the human peroxisome proliferator activated receptor γ cDNA: Expression in hematopoietic cells and chromosomal mapping
18. The organization, promotor analysis and expression of the human PPAR γ gene
19. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers
20. Deletion of 3p25→pter in a primary follicular thyroid carcinoma and its metastasis